ICG: Clinical Trials

84 trials of ICG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 18 unknown, 13 recruiting, 6 terminated. 23 Not applicable, 23 Phase 1, 18 Phase 2, 10 Early Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable23Completed 11, Unknown 5, Recruiting 3, Not yet recruiting 2, Terminated 1, Withdrawn 1
Phase 123Completed 13, Unknown 4, Terminated 3, Recruiting 2, Not yet recruiting 1
Phase 218Completed 9, Unknown 5, Terminated 3, Recruiting 1
Early Phase 110Completed 6, Recruiting 3, Unknown 1
Phase 46Recruiting 2, Unknown 2, Withdrawn 2
Phase 31Recruiting 1

Follow ICG: new trials by email Literature Review of ICG trials Research Report on ICG

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acute Cholecystitis Biliary Complications - ICG
ICG - Acute Cholecystitis, Biliary Complications
Not applicableNot yet recruitingHospital del Mar2962027-01-012026-03-19
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
Gastrectomy, Indocyanine Green, Iron Conjugated Polymers in Saline Suspension - Gastric Adenocarcinoma
Phase 1Not yet recruitingM.D. Anderson Cancer Center202026-12-312026-08-14
Indocyanine Green With Near Infrared Imaging for Intraoperative Visualization of Head and Neck Squamous Cell Carcinoma
Indocyanine green, Near-infrared fluorescence imaging - Head and Neck Squamous Cell Carcinoma
RecruitingWashington University School of Medicine252026-09-302026-10-09
Comparing Intraoperative Indocyanine Green Fluorescence Imaging With Standard Clinical Assessment for Flap Perfusion in Head and Neck Reconstruction (VISION Trial)
Indocyanine Green, Standard clinical perfusion assessment - Head and Neck Cancer (H&N), Free Tissue Flaps
Phase 4RecruitingRegion Skane2442026-09-282026-09-29
Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial
Electronic Health Record Review, Fluorescence Imaging, Fluorescence-Guided Surgery - High Grade Sarcoma, Sarcoma
Phase 2RecruitingCity of Hope Medical Center222026-08-142026-10-16
Application of Indocyanine Green Tracer in D2 Lymphadenectomy of Locally Advanced Gastric Cancer
ICG administration - GASTRIC CANCER, Indocyanine Green (ICG)
Not applicableNot yet recruitingHospital of Navarra1022026-03-012025-03-24
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
Indocyanine Green - Biliary Atresia, Kasai
Early Phase 1RecruitingUniversity of Alabama at Birmingham152026-01-232026-02-18
Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery
Indocyanine Green - Giant Cell Tumor of Bone
Phase 4RecruitingShanghai Jiao Tong University Affiliated Sixth People's Hospital402026-01-022026-01-05
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Ureteral Stent Placement, No Ureteral Stent, Indocyanine Green with Fluorescence Imaging - Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Not applicableRecruitingThomas Jefferson University702025-12-232026-02-17
Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema
Fluid Therapy, Indocyanine Green, Questionnaire Administration - Breast Cancer-Related Lymphedema, Breast Carcinoma
Not applicableWithdrawnCity of Hope Medical Center2025-08-142025-09-17
Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer
Technetium (99mTc), Indocyanine Green, Sentinel lymph node biopsy - Breast Cancer, Sentinel Lymph Node Biopsy (SLNB)
Not applicableRecruitingIsabelle Henskens17602025-04-182026-06-25
Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus
fCTOT cap, NIRF planar imaging, ICG - Post-hemorrhagic Hydrocephalus (PHH)
Phase 1RecruitingEva Sevick202025-01-142025-05-29
Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography
Indocyanine green - Neuroma, Neuroma Amputation
Phase 4WithdrawnNorthwestern University2024-12-282025-01-01
Impact of Intraoperative ICG on Functional Outc in RARP
ICG - Prostate Adenocarcinoma
Early Phase 1RecruitingUniversity of California, Irvine4002024-07-122026-03-03
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
Indocyanine Green - Solid Tumor
Early Phase 1RecruitingSt. Jude Children's Research Hospital252023-10-242026-05-04
Intraoperative Parathyroid Gland (PTG) Identification Using a Hand-Held Imager (HHI)
Parathyroid auto-fluorescence imaging, Indocyanine green - Thyroid Disease, Thyroid Surgery
Phase 1TerminatedOPTOSURGICAL, LLC442023-09-012026-09-22
Feasibility and Utility of Artificial Intelligence (AI) / Machine Learning (ML) - Driven Advanced Intraoperative Visualization and Identification of Critical Anatomic Structures and Procedural Phases in Laparoscopic Cholecystectomy
ICG - Cholecystitis, Cholelithiasis
Not applicableUnknownActiv Surgical1202023-08-012024-02-21
Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery
Indocyanine Green, Fluorescence imaging - Disc Herniation
Phase 1 / Phase 2CompletedZhongnan Hospital402023-04-112025-12-19
Comparison of ICG Microangiography and Conventional Angiography in Severe Frostbite
Indocyanine Green Angiogram - Frostbite
CompletedHealthPartners Institute82023-02-032026-07-30
Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.
Indocyanine green - Gastric Cancer, Gastric Adenocarcinoma
Phase 2TerminatedLaval University112022-12-152024-04-02

Showing 20 of 84. Sign in to see all of them.

Conditions studied

Breast Neoplasms (15)  ·  Stomach Neoplasms (7)  ·  Neoplasms (6)  ·  Carcinoma, Hepatocellular (4)  ·  Cholecystitis (4)  ·  Lung Neoplasms (4)  ·  Arthritis, Rheumatoid (3)  ·  Melanoma (3)  ·  Uterine Cervical Neoplasms (3)  ·  Cholecystitis, Acute (2)  ·  Cholestasis (2)  ·  Esophageal Neoplasms (2)  ·  Fractures, Bone (2)  ·  Head and Neck Neoplasms (2)  ·  Hypocalcemia (2)

Sponsors

Jules Bordet Institute (6)  ·  University of Pennsylvania (5)  ·  Huazhong University of Science and Technology (4)  ·  Centre Hospitalier Universitaire Saint Pierre (3)  ·  Chinese Academy of Sciences (3)  ·  M.D. Anderson Cancer Center (3)  ·  University of Rochester (3)  ·  Washington University School of Medicine (3)  ·  City of Hope Medical Center (2)  ·  Fujian Medical University (2)  ·  Massachusetts General Hospital (2)  ·  National Taiwan University Hospital (2)  ·  Northwestern University (2)  ·  Oxford University Hospitals NHS Trust (2)  ·  St. Jude Children's Research Hospital (2)

Countries

United States (37)  ·  China (16)  ·  Belgium (9)  ·  Netherlands (3)  ·  Spain (3)  ·  Canada (2)  ·  Taiwan (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Qatar (1)  ·  South Korea (1)  ·  Sweden (1)

Top investigators

Ding-Cheng Chan (2)  ·  Isabelle Veys, MD (2)  ·  Jean-Paul Belgrado (2)  ·  Sunil Singhal, MD (2)  ·  Thomas Barnes, MBChB (2)  ·  Alda Tam, MD (1)  ·  Alexandra Lacey, MD (1)  ·  Alexandre Brind'Amour, MD (1)  ·  Ali Zarrinpar, MD, PhD (1)  ·  Andrew Davidoff, MD (1)  ·  Andrew T. Chan, MD, MPH (1)  ·  Annemiek Doeksen, MD, PhD (1)  ·  Antoine Digonnet, MD (1)  ·  Bharat Panuganti, MD, FACS (1)  ·  Chang-Ming Huang, MD (1)

Results publications

PMID 24358319, PMID 27497181, PMID 17013643, PMID 21613624, PMID 25106680, PMID 25304271, PMID 27499979, PMID 27566635, PMID 27586634, PMID 28249726, PMID 28387632, PMID 28623992, PMID 28950327, PMID 29049798, PMID 29290809, PMID 30028985, PMID 30327136, PMID 31188797, PMID 31482242, PMID 32101269, PMID 32224746, PMID 33094400, PMID 33214476, PMID 33754215, PMID 34905086, PMID 35340114, PMID 36686792, PMID 36728303, PMID 36809077, PMID 37121582, PMID 37121591, PMID 37178368, PMID 37194488, PMID 37554762, PMID 37939147, PMID 37973806, PMID 38954670, PMID 40859341, PMID 42342397

NIH funding

P30CA033572 (2), R01AR056702 (2), 2025 (1), P30CA016672 (1), R01CA128919 (1), R01HL092923 (1), R01NS126437 (1), R44CA206754 (1), U54CA136404 (1), U54CA136465 (1)